Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Heart Failure

  Free Subscription


15.11.2021

1 Circ Heart Fail
4 Circulation
1 Clin Cardiol
3 Eur Heart J
1 Eur J Heart Fail
1 Hypertension
2 Int J Cardiol
3 J Card Fail
1 PLoS Med
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Circ Heart Fail

  1. OMAR M, Jensen J, Burkhoff D, Frederiksen PH, et al
    Effect of Empagliflozin on Blood Volume Redistribution in Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis from the Empire HF Randomized Clinical Trial.
    Circ Heart Fail. 2021 Nov 8. doi: 10.1161/CIRCHEARTFAILURE.121.009156.
    PubMed         Abstract available


    Circulation

  2. BURRAGE MK, Hundertmark M, Valkovic L, Watson WD, et al
    Energetic Basis for Exercise-Induced Pulmonary Congestion in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2021 Nov 8. doi: 10.1161/CIRCULATIONAHA.121.054858.
    PubMed        

  3. MENTIAS A, Desai MY, Vaughan-Sarrazin MS, Rao S, et al
    Community-level Economic Distress, Race, and Risk of Adverse Outcomes Following Heart Failure Hospitalization among Medicare Beneficiaries.
    Circulation. 2021 Nov 8. doi: 10.1161/CIRCULATIONAHA.121.057756.
    PubMed         Abstract available

  4. BERG DD, Docherty KF, Sattar N, Jarolim P, et al
    Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients with Heart Failure with Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial.
    Circulation. 2021 Nov 8. doi: 10.1161/CIRCULATIONAHA.121.057852.
    PubMed         Abstract available

  5. HO JE, Nguyen C, Lewis GD
    Unmasking Nonpreserved Heart Structure, Function, and Energetics in Heart Failure With Preserved Ejection Fraction With Magnetic Resonance Imaging Coupled With Exercise.
    Circulation. 2021 Nov 8. doi: 10.1161/CIRCULATIONAHA.121.056974.
    PubMed        


    Clin Cardiol

  6. PACHECO C, Wei J, Shufelt C, C Hitzeman T, et al
    Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarker.
    Clin Cardiol. 2021 Sep 16. doi: 10.1002/clc.23726.
    PubMed         Abstract available


    Eur Heart J

  7. ISHIURA J, Nakamori S, Ishida M, Dohi K, et al
    'Targeting the cardiac myocyte and fibrosis' in heart failure.
    Eur Heart J. 2021 Nov 10. pii: 6425003. doi: 10.1093.
    PubMed        

  8. LUND LH, Hage C, Savarese G
    Implementation science and potential for screening in heart failure.
    Eur Heart J. 2021 Nov 9. pii: 6424186. doi: 10.1093.
    PubMed        

  9. EGIDY ASSENZA G, Dimopoulos K, Budts W, Donti A, et al
    Management of acute cardiovascular complications in pregnancy.
    Eur Heart J. 2021;42:4224-4240.
    PubMed         Abstract available


    Eur J Heart Fail

  10. SEFEROVIC PM, Polovina M, Adlbrecht C, BElohlavek J, et al
    Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline-directed medical treatment in heart failure with reduced ejection fraction.
    Eur J Heart Fail. 2021 Nov 9. doi: 10.1002/ejhf.2378.
    PubMed         Abstract available


    Hypertension

  11. MOLSBERRY RJ, Rethy L, Wang MC, Mehta RC, et al
    Risk-Based Intensive Blood Pressure Lowering and Prevention of Heart Failure: A SPRINT Post Hoc Analysis.
    Hypertension. 2021;78:1742-1749.
    PubMed         Abstract available


    Int J Cardiol

  12. SARDU C, Amarelli C
    Continuous flow left ventricular assist devices and cardiac resynchronization: Friends or foe?
    Int J Cardiol. 2021;344:138-139.
    PubMed        

  13. LIANG Y, Ding R, Wang J, Gong X, et al
    Prediction of response after cardiac resynchronization therapy with machine learning.
    Int J Cardiol. 2021;344:120-126.
    PubMed         Abstract available


    J Card Fail

  14. PODSIADLY A, Paleczny B, Olesinska-Mader M, Nowak K, et al
    Valsalva-derived measures and phenylephrine test in patients with heart failure with reduced ejection fraction receiving comprehensive neurohormonal blockade drug therapy: a 5-year event-free survival analysis.
    J Card Fail. 2021 Nov 7. pii: S1071-9164(21)00438.
    PubMed         Abstract available

  15. CALIFF RM
    The Ecosystem to Support People with Heart Failure.
    J Card Fail. 2021 Nov 6. pii: S1071-9164(21)00441.
    PubMed        

  16. OMAR HR, Guglin M
    Higher Requirements of Loop Diuretics in Heart Failure With Chronic Kidney Disease Regardless of Degree of Left Ventricular Dysfunction: From the HF-ACTION trial.
    J Card Fail. 2021;27:1295-1297.
    PubMed        


    PLoS Med

  17. HOU Y, Zhou Y, Hussain M, Budd GT, et al
    Cardiac risk stratification in cancer patients: A longitudinal patient-patient network analysis.
    PLoS Med. 2021;18:e1003736.
    PubMed         Abstract available


    PLoS One

  18. IWAHANA T, Saito Y, Okada S, Kato H, et al
    Safety and efficacy of esaxerenone in Japanese hypertensive patients with heart failure with reduced ejection fraction: A retrospective study.
    PLoS One. 2021;16:e0259485.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: